Xtant Medical to Announce Fourth Quarter and Full Year 2025 Financial Results on March 31, 2026

BELGRADE, Mont., March 25, 2026 /PRNewswire/ --

(NYSE American: XTNT), a medical technology company focused on surgical solutions for spinal and other orthopedic conditions, today announced that it will release its financial results for the fourth quarter and full year ended December 31, 2025, before the start of trading on Tuesday, March 31, 2026. Sean Browne, President and Chief Executive Officer, and Scott Neils, Chief Financial Officer, will host a conference call at 8:30 AM ET on that day.

Conference Date: Tuesday, March 31, 2026

Conference Time: 8:30 AM ET

Conference Dial-in: 888-506-0062

International Dial-in: 973-528-0011

Passcode: 581090

Conference Call Name: Xtant Medical Q4 2025 Financial Results

Xtant Medical's mission of honoring the gift of donation so that our patients can live as full and complete a life as possible, is the driving force behind our company. Xtant Medical Holdings, Inc. is a global medical technology company focused on the design, development, and commercialization of a comprehensive portfolio of orthobiologics serving the chronic and surgical wound care and sports medicine markets, as well as spinal implant systems. Xtant people are dedicated and talented, operating with the highest integrity to serve our customers.

The symbols ™ and ® denote trademarks and registered trademarks of Xtant Medical Holdings, Inc. or its affiliates, registered as indicated in the United States, and in other countries. All other trademarks and trade names referred to in this release are the property of their respective owners.

View original content to download multimedia:

SOURCE Xtant Medical Holdings, Inc.